Detalhe da pesquisa
1.
The Bone's Role in Myeloid Neoplasia.
Int J Mol Sci
; 21(13)2020 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32630305
2.
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
Blood
; 130(23): 2499-2503, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972014
3.
**-Postprandial pancreatic [11C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release.
Eur J Nucl Med Mol Imaging
; 44(3): 509-516, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27389029
4.
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia.
Haematologica
; 106(8): 2251-2256, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626863
5.
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Leukemia
; 37(11): 2250-2260, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673973
6.
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Cancer Discov
; 12(2): 372-387, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635570
7.
CXCR4 PET imaging of mantle cell lymphoma using [68Ga]Pentixafor: comparison with [18F]FDG-PET.
Theranostics
; 11(2): 567-578, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391493
8.
The relationship between cholecystokinin secretion and pancreatic [11C]methionine uptake in patients after partial pancreaticoduodenectomy.
Ann Nucl Med
; 34(9): 691-695, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654031
9.
In Human Visualization of Ibrutinib-Induced CLL Compartment Shift.
Cancer Immunol Res
; 8(8): 984-989, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580942
10.
Gastric Emptying and Distal Gastrectomy Independently Enhance Postprandial Glucagon-Like Peptide-1 Release After a Mixed Meal and Improve Glycemic Control in Subjects Having Undergone Pancreaticoduodenectomy.
Pancreas
; 48(7): 953-957, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268979
11.
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.
Lancet Haematol
; 4(12): e595-e606, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153976
12.
Blood cancer driver Musashi-2 as therapeutic target in chronic lymphocytic leukemia.
Leukemia
; 35(4): 982-983, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654207